HCM
ELV icon

Highline Capital Management’s Elevance Health ELV Stock Holding History

Highline Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-246,000
Closed -$69.4M – 30
2019
Q2 		$69.4M Sell
246,000
-32,858
-12% -$8.98M 5.08% 6
2019
Q1 		$80M Sell
278,858
-59,206
-18% -$17.1M 5.03% 6
2018
Q4 		$88.8M Buy
+338,064
New +$93M 5.95% 6

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Highline Capital Management's ELV Position: Q3 2019 in Review

Highline Capital Management sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 246,000 shares — an estimated $69.4M sold.

Highline Capital Management first reported a position in ELV in Q4 2018 and held it in 3 quarters. The position peaked at $88.8M in Q4 2018. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Highline Capital Management reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Highline Capital Management sold 246,000 Elevance Health shares in Q3 2019, an estimated $69.4M.
  • Highline Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 3 quarters.
  • Highline Capital Management's Elevance Health position peaked at $88.8M in Q4 2018.
  • 1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Highline Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.